MSB 8.43% $1.35 mesoblast limited

Analysis of the EAP, page-388

  1. 6,122 Posts.
    lightbulb Created with Sketch. 1060
    @ImaScientist



    I have watched that video many times. For others, if you haven't watched it do yourself a favour and watch the whole video.

    MSCs niche are perivascular. They have innate homing ability, they engraft as pericytes and heal.

    MSCs dock at points of injury, the have an immunomodulatory and regenerative component. They are the managers of your innate regenerative potential.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.